A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
Public ClinicalTrials.gov record NCT00063726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Non-Comparative, Open-Label Study of PS-341 Administered to Patients With Multiple Myeloma Who Experienced Relapsed or Progressive Disease After Receiving at Least Four Previous Treatment Regimens or Experienced Progressive Disease After Receiving Dexamethasone in Millennium Protocol M34101-039
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to allow patients to receive VELCADE™ (bortezomib) for Injection who experienced progressive disease(PD) while receiving high-dose dexamethasone from the M34101-039 study.
Study identification
- NCT ID
- NCT00063726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2002 (Type not available)
- Primary completion
- May 2005 (Actual)
- Completion
- Jul 2005 (Actual)
- Last update posted
- Jan 13, 2012
2002 – 2005
United States locations
- U.S. sites
- 39
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| City of Hope | Duarte | California | 91010 | — |
| Scripps Clinic, Green Cancer Center | La Jolla | California | 92307 | — |
| Loma Linda University Medical Center | Loma Linda | California | 92354 | — |
| Kaiser Permanente Medical Center | Vallejo | California | 94589 | — |
| Lombardi Cancer Center, Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Med Star Institute | Washington D.C. | District of Columbia | 20010 | — |
| Hematology/Oncology Associates, PA | Jacksonville | Florida | 32207 | — |
| University of Miami | Miami | Florida | 33136 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Northwestern University Medical School | Chicago | Illinois | 60611 | — |
| Loyola University Medical Center: Cardinal Bernardin Cancer Center | Maywood | Illinois | 60153 | — |
| LSU HC | Sheveport | Louisiana | 71130 | — |
| Tufts England Medical Center | Boston | Massachusetts | 02111 | — |
| Mass General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Center | Boston | Massachusetts | 02115 | — |
| Univ. of Michigan Comp. Cancer Center, | Ann Arbor | Michigan | 48109-0922 | — |
| VA Medical Center | Minneapolis | Minnesota | 55417 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center, David Jurist Research Building | Hackensack | New Jersey | 07601 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Long Island Jewish Medical Center | New Hyde Park | New York | 11040 | — |
| St. Vincent's Comprehensive Cancer Center | New York | New York | 10011 | — |
| Weill Medical College of Cornell University, NY Presbyterian Hospital | New York | New York | 10021 | — |
| Rochester General Hospital | Rochester | New York | 14621 | — |
| University of Rochester Medical Center, James P. Wilmot Cancer Center | Rochester | New York | 14642 | — |
| Charlotte Hematology Oncology Associates | Charlotte | North Carolina | 28203 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| Trident Palmetto Hematology/Oncology | Charleston | South Carolina | 29406 | — |
| Division of Hematology/Stem Cell Transplant | Nashville | Tennessee | 37232-5505 | — |
| Texas Oncology at Medical City Dallas Hospital | Dallas | Texas | 75225 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00063726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 13, 2012 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00063726 live on ClinicalTrials.gov.